| CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016 QT Ostrom, G Cioffi, H Gittleman, N Patil, K Waite, C Kruchko, ... Neuro-oncology 21 (Supplement_5), v1-v100, 2019 | 2427 | 2019 |
| CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017 QT Ostrom, N Patil, G Cioffi, K Waite, C Kruchko, JS Barnholtz-Sloan Neuro-oncology 22 (Supplement_1), iv1-iv96, 2020 | 1640 | 2020 |
| CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018 QT Ostrom, G Cioffi, K Waite, C Kruchko, JS Barnholtz-Sloan Neuro-oncology 23 (Supplement_3), iii1-iii105, 2021 | 1104 | 2021 |
| CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019 QT Ostrom, M Price, C Neff, G Cioffi, KA Waite, C Kruchko, ... Neuro-oncology 24 (Supplement_5), v1-v95, 2022 | 655 | 2022 |
| Brain and other central nervous system tumor statistics, 2021 KD Miller, QT Ostrom, C Kruchko, N Patil, T Tihan, G Cioffi, HE Fuchs, ... CA: a cancer journal for clinicians 71 (5), 381-406, 2021 | 637 | 2021 |
| Association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed … AM Molinaro, S Hervey-Jumper, RA Morshed, J Young, SJ Han, ... JAMA oncology 6 (4), 495-503, 2020 | 426 | 2020 |
| CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in … QT Ostrom, M Price, K Ryan, J Edelson, C Neff, G Cioffi, KA Waite, ... Neuro-oncology 24 (Supplement_3), iii1-iii38, 2022 | 122 | 2022 |
| CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2016—2020 QT Ostrom, M Price, C Neff, G Cioffi, KA Waite, C Kruchko, ... Neuro-oncology 25 (Supplement_4), iv1-iv99, 2023 | 121 | 2023 |
| Sex differences in cancer incidence and survival: a pan-cancer analysis M Dong, G Cioffi, J Wang, KA Waite, QT Ostrom, C Kruchko, JD Lathia, ... Cancer Epidemiology, Biomarkers & Prevention 29 (7), 1389-1397, 2020 | 112 | 2020 |
| Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for clinicians JT Low, QT Ostrom, G Cioffi, C Neff, KA Waite, C Kruchko, ... Neuro-oncology practice 9 (3), 165-182, 2022 | 92 | 2022 |
| Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015 H Gittleman, G Cioffi, T Vecchione-Koval, QT Ostrom, C Kruchko, ... Journal of Neuro-oncology 143, 251-260, 2019 | 68 | 2019 |
| 5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers Y Zhao, X Feng, Y Chen, JE Selfridge, S Gorityala, Z Du, JM Wang, Y Hao, ... Cancer research 80 (21), 4815-4827, 2020 | 62 | 2020 |
| Descriptive epidemiology of craniopharyngiomas in the United States AA Momin, MA Recinos, G Cioffi, N Patil, P Soni, JP Almeida, C Kruchko, ... Pituitary 24, 517-522, 2021 | 50 | 2021 |
| Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas GM Wang, G Cioffi, N Patil, KA Waite, R Lanese, QT Ostrom, C Kruchko, ... Neuro-oncology 24 (2), 302-310, 2022 | 41 | 2022 |
| An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival H Gittleman, G Cioffi, P Chunduru, AM Molinaro, MS Berger, AE Sloan, ... Neuro-oncology advances 1 (1), vdz007, 2019 | 39 | 2019 |
| Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017 N Patil, ME Kelly, DN Yeboa, RA Buerki, G Cioffi, S Balaji, QT Ostrom, ... Neuro-oncology 23 (6), 990-998, 2021 | 38 | 2021 |
| Molecular biomarker-defined brain tumors: epidemiology, validity, and completeness in the United States JB Iorgulescu, C Sun, C Neff, G Cioffi, C Gutierrez, C Kruchko, J Ruhl, ... Neuro-oncology 24 (11), 1989-2000, 2022 | 35 | 2022 |
| National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States QT Ostrom, ML Shoaf, G Cioffi, K Waite, C Kruchko, PY Wen, DJ Brat, ... Neuro-oncology 25 (4), 799-807, 2023 | 33 | 2023 |
| A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act SJ Reihl, N Patil, RA Morshed, M Mehari, A Aabedi, UN Chukwueke, ... Neuro-oncology 24 (8), 1341-1349, 2022 | 24 | 2022 |
| An updated histology recode for the analysis of primary malignant and nonmalignant brain and other central nervous system tumors in the Surveillance, Epidemiology, and End … G Forjaz, JS Barnholtz-Sloan, C Kruchko, R Siegel, S Negoita, QT Ostrom, ... Neuro-oncology advances 3 (1), vdaa175, 2021 | 22 | 2021 |
